Individual responses to chemotherapy-induced oxidative stress

Breast Cancer Research and Treatment

Volumn 125, Issue 2, 2011, Pages 583-589

  Il'yasova, Dora ^a   Kennedy, Kelly ^b   Spasojevic, Ivan ^a   Wang, Frances ^a   Tolun, Adviye A ^b   Base, Karel ^a   Young, Sarah P ^b   Kelly Marcom, P ^a   Marks, Jeffrey ^a   Millington, David S ^b   Dewhirst, Mark W ^b  

^a DUKE CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

Biomarker; Chemotherapy; Epidemiology; Oxidative stress

Indexed keywords

2,3 DINOR ISOPROSTANE 2ALPHA; 8,12 ISOPROSTANE 2ALPHA; ALLANTOIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ISOPROSTANE 2ALPHA; ISOPROSTANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; URINE LEVEL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHROMATOGRAPHY, LIQUID; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TANDEM MASS SPECTROMETRY; TIME FACTORS; TREATMENT OUTCOME;

EID: 78650975868     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1158-7     Document Type: Article

References (31)

1. JH Doroshow 2006 Redox modulation of chemotherapy-induced tumor cell killing and normal tissue toxicity J Natl Cancer Inst 98 223 225 1:CAS:528:DC%2BD28Xhs1Skt70%3D 10.1093/jnci/djj065 16478735 (Pubitemid 43264705)
2. B Halliwell M Whiteman 2004 Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142 231 255 1:CAS:528:DC%2BD2cXkvVyks7w%3D 10.1038/sj.bjp.0705776 15155533 (Pubitemid 38746160)
3. G Block M Dietrich EP Norkus JD Morrow M Hudes B Caan L Packer 2002 Factors associated with oxidative stress in human populations Am J Epidemiol 156 274 285 10.1093/aje/kwf029 12142263 (Pubitemid 34810481)
4. Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine. Oxford University Press, Oxford
5. W Droge 2002 Free radicals in the physiological control of cell function Physiol Rev 82 47 95 1:CAS:528:DC%2BD38XovFSisw%3D%3D 11773609
6. D Il'yasova I Spasojevich F Wang AA Tolun K Base SP Young PK Marcom J Marks G Mixon R Di Giulio DS Millington 2010 Urinary biomarkers of oxidative status in a clinical model of oxidative assault Cancer Epidemiol Biomarkers Prev 19 6 1506 1510 10.1158/1055-9965.EPI-10-0211 10.1158/1055-9965.EPI-10-0211 20501773
7. D Il'yasova G Mixon F Wang PK Marcom J Marks I Spasojevich N Craft F Arredondo R DiGiulio 2009 Markers of oxidative status in a clinical model of oxidative assault: a pilot study in human blood following doxorubicin administration Biomarkers 14 321 325 10.1080/13547500902946757 19476408
8. AA Tolun H Zhang D Il'yasova J Sztbray SP Young DS Millington 2010 Allantoin in human urine quantified by ultra-performance liquid chromatography-tandem mass spectrometry Anal Biochem 402 191 193 1:CAS:528:DC%2BC3cXmsVCqsLY%3D 10.1016/j.ab.2010.03.033 20361921
9. DF Stowe AK Camara 2009 Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function Antioxid Redox Signal 11 1373 1414 1:CAS:528:DC%2BD1MXkvVGnsbY%3D 10.1089/ars.2008.2331 19187004
10. PS Brookes 2005 Mitochondrial H(+) leak and ROS generation: an odd couple Free Radic Biol Med 38 12 23 1:CAS:528:DC%2BD2cXhtVKrt7fK 10.1016/j. freeradbiomed.2004.10.016 15589367 (Pubitemid 39626904)
11. K Bedard KH Krause 2007 The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev 87 245 313 1:CAS:528: DC%2BD2sXitVagsr4%3D 10.1152/physrev.00044.2005 17237347 (Pubitemid 46209993)
12. CX Santos LY Tanaka J Wosniak FR Laurindo 2009 Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase Antioxid Redox Signal 11 2409 2427 1:CAS:528:DC%2BD1MXhtFCktb7N 10.1089/ars.2009.2625 19388824
13. J Wosniak Jr CX Santos AJ Kowaltowski FR Laurindo 2009 Cross-talk between mitochondria and NADPH oxidase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells Antioxid Redox Signal 11 1265 1278 1:CAS:528:DC%2BD1MXkvVGnsbw%3D 10.1089/ars.2009.2392 19281299
14. LR Lopes MC Dagher A Gutierrez B Young AP Bouin A Fuchs BM Babior 2004 Phosphorylated p40PHOX as a negative regulator of NADPH oxidase Biochemistry 43 3723 3730 1:CAS:528:DC%2BD2cXhs1yitro%3D 10.1021/bi035636s 15035643 (Pubitemid 38391727)
15. MM Desouki M Kulawiec S Bansal GM Das KK Singh 2005 Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors Cancer Biol Ther 4 1367 1373 1:CAS:528:DC%2BD28XkvVOhu7g%3D 10.4161/cbt.4.12.2233 16294028
16. S Fogarty DG Hardie 2010 Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer Biochim Biophys Acta 1804 581 591 1:CAS:528:DC%2BC3cXhs1ymsrk%3D 19778642
17. J Lin C Handschin BM Spiegelman 2005 Metabolic control through the PGC-1 family of transcription coactivators Cell Metab 1 361 370 10.1016/j.cmet.2005. 05.004 16054085 (Pubitemid 43960626)
18. SH Chan CA Wu KL Wu YH Ho AY Chang JY Chan 2009 Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension Circ Res 105 886 896 1:CAS:528:DC%2BD1MXhsVCiurrL 10.1161/CIRCRESAHA.109.199018 19762685
19. C Handschin 2009 Peroxisome proliferator-activated receptor-gamma coactivator-1alpha in muscle links metabolism to inflammation Clin Exp Pharmacol Physiol 36 1139 1143 1:CAS:528:DC%2BD1MXhsF2gs77L 10.1111/j.1440-1681.2009. 05275.x 19671064
20. BB Kahn T Alquier D Carling DG Hardie 2005 AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism Cell Metab 1 15 25 1:CAS:528:DC%2BD2MXhtlaqs74%3D 10.1016/j.cmet.2004.12.003 16054041 (Pubitemid 43960587)
21. A Lombardi A de Lange E Silvestri RA Busiello A Lanni F Goglia M Moreno 2009 3, 5-Diiodo-L-thyronine rapidly enhances mitochondrial fatty acid oxidation rate and thermogenesis in rat skeletal muscle: AMP-activated protein kinase involvement Am J Physiol Endocrinol Metab 296 3 E497 E502 1:CAS:528: DC%2BD1MXjtFGrt70%3D 10.1152/ajpendo.90642.2008 19116374
22. D Il'yasova JD Morrow LE Wagenknecht 2005 Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes Obes Res 13 1638 1644 10.1038/oby.2005.201 16222068
23. Y Olmos I Valle S Borniquel A Tierrez E Soria S Lamas M Monsalve 2009 Mutual dependence of Foxo3a and PGC-1alpha in the induction of oxidative stress genes J Biol Chem 284 14476 14484 1:CAS:528:DC%2BD1MXlvV2isrg%3D 10.1074/jbc.M807397200 19324885
24. J St-Pierre S Drori M Uldry JM Silvaggi J Rhee S JSger C Handschin K Zheng J Lin W Yang DK Simon R Bachoo BM Spiegelman 2006 Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators Cell 127 397 408 1:CAS:528:DC%2BD28XhtFOkt7rM 10.1016/j.cell.2006.09.024 17055439 (Pubitemid 44572377)
25. X Kong H Fan X Liu R Wang J Liang N Gupta Y Chen F Fang Y Chang 2009 Peroxisome proliferator-activated receptor gamma coactivator-1alpha enhances antiproliferative activity of 5'-deoxy-5-fluorouridine in cancer cells through induction of uridine phosphorylase Mol Pharmacol 76 854 860 1:CAS:528: DC%2BD1MXht1eitrnO 10.1124/mol.109.056424 19602572
26. L Wojnowski B Kulle M Schirmer G Schluter A Schmidt A Rosenberger S Vonhof H Bickeboller MR Toliat EK Suk M Tzvetkov A Kruger S Seifert M Kloess H Hahn M Loeffler P Nurnberg M Pfreundschuh L Trumper J Brockmoller G Hasenfuss 2005 NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity Circulation 112 3754 3762 1:CAS:528:DC%2BD2MXht1yitb7K 10.1161/CIRCULATIONAHA.105.576850 16330681 (Pubitemid 43739516)
27. M Hoffmann MA Schirmer MV Tzvetkov M Kreuz M Ziepert L Wojnowski D Kube M Pfreundschuh L Trumper M Loeffler J Brockmoller 2010 A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphoma Cancer Res 70 2328 2338 1:CAS:528:DC%2BC3cXjtFygtL4%3D 10.1158/0008-5472.CAN-09-2388 20215507
28. M Landriscina F Maddalena G Laudiero F Esposito 2009 Adaptation to oxidative stress, chemoresistance, and cell survival Antioxid Redox Signal 11 2701 2716 1:CAS:528:DC%2BD1MXht1Ojt7nE 10.1089/ars.2009.2692 19778285
29. JD Pennington TJ Wang P Nguyen L Sun K Bisht D Smart D Gius 2005 Redox-sensitive signaling factors as a novel molecular targets for cancer therapy 1 Drug Resist Updat 8 322 330 1:CAS:528:DC%2BD2MXht1Oms7zM 10.1016/j.drup.2005.09.002 16230045 (Pubitemid 41677715)
30. A Yokomizo M Ono H Nanri Y Makino T Ohga M Wada T Okamoto J Yodoi M Kuwano K Kohno 1995 Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide 1 Cancer Res 55 4293 4296 1:CAS:528:DyaK2MXotlKnu7k%3D 7671238
31. JB Mitchell A Russo 1987 The role of glutathione in radiation and drug induced cytotoxicity 1 Br J Cancer Suppl 8 96 104 1:STN:280: DyaL1c%2FgtVertw%3D%3D 3307879